MissionIR Articles
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
HeartBeam (NASDAQ: BEAT), a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss third-quarter results and share updates on regulatory developments and ongoing projects. CEO Robert Eno, Founder and President Dr. Branislav Vajdic, and CFO Timothy Cruickshank will…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Details Promising Phase 3 Path for Alzheimer’s Treatment on The BioMedWire Podcast
Annovis Bio (NYSE: ANVS) led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer’s and Parkinson’s drug candidate, buntanetap. In her interview on IBN’s BioMedWire Podcast, Dr. Maccecchini discusses Annovis Bio’s recent FDA clearance to proceed with pivotal Phase 3 trials for early-stage Alzheimer’s patients, a critical step toward…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatments to Patients
Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in both Alzheimer’s and Parkinson’s patients. The company also introduced a new crystalline form of buntanetap with improved properties, “offering significant…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced an upcoming meeting with U.S. Food and Drug Administration (“FDA”) leadership. The focus is to…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, was recognized with the 2024 Digital Health Hub Rising Star award in the ‘Home Health Diagnostic’ category at the HLTH global healthcare conference. The award highlights HeartBeam’s innovative vector-based technology, which captures heart electrical signals in three dimensions to provide detailed cardiac insights.…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Introduces Service-Level Agreements to Support Customers’ Production Applications
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, announced Thursday morning that it has introduced service level agreements (“SLAs”) to support Leap™ quantum cloud service customers as they move quantum applications into production. The formal SLAs represent D-Wave’s commitment to providing high levels of availability, reliability and scalability…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces 5-Year Contract to Provide Advanced Electronic Monitoring Solutions to the Israel Prison Service State Agency
SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, and its prime partner Electra, a security services provider in Israel, have been awarded a 5-year contract by the Israel Prison Service state agency (“IPS”). The full-service contract, which is already in effect and includes an optional extension…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Fireside Chat at 2024 Healthcare Virtual Summit
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming 2024 Healthcare Virtual Summit. The summit, which is presented by Maxim Group LLC, is scheduled for Oct. 16, 2024. According to the announcement,…
-
MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Reports on Private Placement Valued at Estimated $8.2M
SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, has released certain information regarding a private placement. The placement, which is with certain institutional investors, is projected to result in an estimated $8.2 million for the company, before the deduction of standard fees and costs. SOBRsafe anticipates using the funds for working capital and…
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Announces ‘Significant’ Extension and Expansion of Exclusive Distribution Agreement with OPKO Health
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that its original exclusive e-commerce distribution contract with OPKO Health Inc. (NASDAQ: OPK) has been extended for four years and expanded to include additional e-commerce platforms and digital and social media marketing across China. The original agreement allowed NextPlat to sell OPKO Health Europe’s nutraceutical…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Forecasts $75M in GAAP Revenue Over Next 6 Months, Implements Immediate Measures to Cut Overall Expenses
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it expects to ramp up its commercial sales to a monthly average of $12.5 million. As a result, the company forecasts $75 million in estimated GAAP revenue over the next six months from both Mullen Commercial’s and its subsidiary Bollinger Motors’ sales…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Reports 6791% QoQ Revenue Growth, Continued Decrease in Monthly Cash Burn
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced expectations to report a significant revenue increase for the quarter ended September 30, 2024. The company anticipates recording approximately $4.5 million in revenue in the just-ended quarter, compared to $65,235.00 in the previous quarter ended June 30, 2024, a quarter-over-quarter increase of 6791%.…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, and its wholly owned subsidiary, Clene Nanomedicine Inc., has closed on a registered direct offering and concurrent private placements. According to the announcement, the transactions consist of common stock and warrants and were with…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Japan Tobacco Inc. Announce Planned Partnership to Leverage Quantum Computing, AI in Drug Discovery
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”) announced plans to partner on a joint proof-of-concept project to explore the use of quantum computing technology and artificial intelligence (“AI”) to accelerate the speed and quality of the drug discovery…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements Totaling $7.3M
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has entered into a securities purchase agreement. The company entered the agreement, which calls for the issue and sale of 742,626 shares of common stock (or prefunded warrants in lieu thereof) with a healthcare-focused…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the study, which aims to investigate the first ever DehydraTECH-processed version of tirzepatide, a dual action…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Video Update from CEO
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared a video update to shareholders provided by CEO and Chairman David Michery. In the video, Michery provides a detailed overview of the company’s recent progress, including sales and distribution expansion and financial performance. According to the update, the company’s sales activities with existing…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology
Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is announcing that its patent application, which protects its AVERSA(TM) abuse deterrent transdermal technology, has been allowed in China. This follows the receipt of a Notice of Allowance from the Chinese National Intellectual Property Administration (“CNIPA”) for the application entitled “Abuse and…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that CEO John Climaco will present at the 24th Annual Biotech in Europe Forum. The presentation is scheduled for Wednesday, September 25, 2024, at 1:55 p.m. CEST…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Advances The Dream Bowl With Tokenized Autographs, National ESPN+ Broadcast
- MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Eyes Increased Adoption of Solutions Across Core Markets
- MissionIRNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Leveraging District-Scale Upside in Alaska’s Ambler Mining District
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Appoints Kasowitz LLP to Strengthen Intellectual Property and Litigation Capabilities
- GlobalTech Corp. (GLTK) Closes Acquisition of Moda in Pelle and Is Redefining Intelligent Retail with AI